ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HCID 4617作成日:2026年10月27日

オキサゾラム

ネブスン · オキサゾラム · 10-クロロ-2,3,7,11b-テトラヒドロ-2-メチル-11b-フェニルオキサゾロ[3,2-d][1,4]ベンゾジアゼピン-6(5H)-オン · ペルサール · セレナール · トッカータ · セレナル【日本】 · オキサゾラム (JP17)

https://huagongshe.com/ja/chemical/4617

オキサゾラム の分子構造式

識別子と物理属性

CAS No.24143-17-7
分子式C18H17ClN2O2
平均分子量328.8 g/mol
単同位体質量328.0978555 g/mol
SMILESCC1CN2CC(=O)Nc3ccc(Cl)cc3C2(c2ccccc2)O1
InChIKeyVCCZBYPHZRWKFY-UHFFFAOYSA-N
PubChem CID4617
ChEMBLCHEMBL2104805
ChEBICHEBI:31944
EC No.246-032-0
DTXSIDDTXSID5023401
現地名オキサゾラム

化学・物理的性質

XLogP3
極性表面積41.6
水素結合供与体数1
水素結合受容体数3
回転可能結合数1
重原子数23
形式電荷0
複雑度468
Kovats Retention Index25642569258625962590
融点187°C
沸点495.8±45.0 °C(Predicted)
密度1.2065 (rough estimate)
屈折率1.5400 (estimate)
引火点11 °C
貯蔵条件2-8°C
溶解度Chloroform (Slightly), Methanol (Slightly)
pKa(酸解離定数)12.85±0.60(Predicted)
外観・状態固体

安全性と法規制

GHS 分類DangerH301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]H331 (100%): Toxic if inhaled [Danger Acute toxicity, inhalation]P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
規制情報DEA schedule IV controlled substance
Hazard Classes and CategoriesAcute Tox. 3 (100%)Skin Irrit. 2 (100%)Eye Irrit. 2 (100%)
TreatmentGeneral supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

用途

解説

オキサゾラム.N-(2-ベンゾイル-4-クロロフェニル)ブロモアセトアミドと1-アミノ-2-プロパノールとを加熱反応させると得られる.白色の結晶性粉末.融点約187 ℃.酢酸に易溶,1,4-ジオキサン,ジクロロメタンに可溶,エタノール,エーテルに難溶,水に不溶.トランキライザーとして用いられる.LD50 5200 mg/kg(マウス,経口).

用途

ベンゾジアゼピン系化合物で す。GABA受容体に作用し、中枢神経抑制作 用を示します。作用時間は、長時間型とされ ています。

用途

ベンゾジアゼピン系化合物で す。GABA 受容体に作用し、中枢神経抑制作 用を示します。作用時間は、長時間型とされ ています。

使用

A psychotropic agent with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is a precursor to the active substance Desmethyldiazepam (D291595).

毒性の概要Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
毒性LD50 orl-mus: 5200 mg/kg NYKZAU 66,107,70
危険文句(R)11-23/24/25-39/23/24/25-36/38-23/25
危険表示F,T
安全措置(S)16-36/37-45-24
DEA Controlled SubstancesCSCN: 2839CSA SCH: Schedule IVNARC: No